{"url_path":"/sec/ofix/8-k/2026-06-11/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-11","source_url":"https://www.sec.gov/Archives/edgar/data/884624/0001193125-26-266679-index.html","accession_number":"0001193125-26-266679","cik":"0000884624","ticker":"OFIX","issuer_name":"Orthofix Medical Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/884624/0001193125-26-266679-index.html","primary_entity_key":"0000884624","primary_entity_name":"Orthofix Medical Inc."},"word_count":336,"has_tables":true,"body_markdown":"Item 5.07 Submission of Matters to a Vote of Security Holders.\n\nOn June 10, 2026, the Company held the Annual Meeting. The total number of common shares eligible to vote as of the record date, April 13, 2026, was 40,385,869 and, pursuant to the Company’s Bylaws, 20,192,935 shares were required to be present or represented at the Annual Meeting to constitute a quorum. The total number of common shares present or represented at the Annual Meeting was 34,776,676, and a quorum therefore existed. Of the shares present and represented, 4,704,457 constituted broker non-votes for purposes of items 1, 2 and 4 below.\n\nAt the Annual Meeting:\n\n1.\n\nElection of Board of Directors. The following persons were elected as directors of the Company for a one-year term expiring at the 2027 Annual Meeting of Shareholders:\n\n \n\nName\n\nVotes For\n\nVotes Against\n\nAbstentions\n\nAlan L. Bazaar\n\n29,026,559\n\n1,014,417\n\n31,243\n\nWayne Burris\n\n24,898,636\n\n5,162,812\n\n10,771\n\nMassimo Calafiore\n\n29,344,227\n\n725,358\n\n2,634\n\nVickie L. Capps\n\n29,373,109\n\n667,919\n\n31,191\n\nMichael M. Finegan\n\n29,238,156\n\n827,899\n\n6,164\n\nJason M. Hannon\n\n29,389,134\n\n676,817\n\n6,268\n\nJohn B. Henneman, III\n\n28,798,930\n\n1,262,304\n\n10,985\n\nCharles R. Kummeth\n\n28,990,854\n\n1,070,316\n\n11,049\n\nShweta S. Maniar\n\n29,631,030\n\n434,784\n\n6,405\n\nMichael E. Paolucci\n\n24,698,858\n\n5,367,249\n\n6,112\n\n \n\n2.\n\nAdvisory and Non-Binding Resolution to Approve Executive Compensation. The advisory and non-binding resolution to approve executive compensation was approved by a vote of (i) 24,480,474 in favor, (ii) 5,577,200 against, and (iii) 14,545 abstaining.\n\n##  \n\n \n\n3.\n\nRatification of the Selection of Ernst & Young LLP. The selection of Ernst & Young LLP to act as the independent registered public accounting firm for the Company and its subsidiaries for the fiscal year ending December 31, 2026 was ratified by a vote of (i) 33,262,505 in favor, (ii) 1,384,292 against, and (iii) 129,879 abstaining.\n\n##  \n\n \n\n4.\n\nApproval of Amendment No. 5 to the Second Amended and Restated Stock Purchase Plan. Shareholders approved Amendment No. 5 to the Company’s Second Amended and Restated Stock Purchase Plan by a vote of (i) 29,235,005 in favor, (ii) 831,625 against, and (iii) 5,589 abstaining."}